Physician profile
Shawn E Cotton
NPI 1003880113
$1,990.83
in general payments reported to CMS, 2019-2025
15 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $628 · 2021: $71.12 · 2022: $372 · 2023: $39.41 · 2024: $361 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $565.75 | 2019-2025 | Breztri, Farxiga |
| Abbvie INC. | $357.46 | 2021-2024 | |
| Novo Nordisk INC | $347.19 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $258.10 | 2019-2024 | Mounjaro |
| Astellas Pharma US INC | $187.91 | 2019 | |
| Pfizer INC. | $79.12 | 2019-2024 | |
| Abbott Laboratories | $45.40 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.63 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.10 | 2022 | |
| Sunovion Pharmaceuticals INC. | $22.74 | 2020 | |
| Eisai INC. | $19.07 | 2020 | |
| Amarin Pharma, INC. | $16.21 | 2020 | |
| Allergan, INC. | $13.67 | 2020 | |
| Genentech USA, INC. | $11.62 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Cotton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.